TAFALGIE THERAPEUTICS is a simplified joint-stock biotechnology company, Spin-off of the IBDM laboratory (AMU/CNRS).

The society is created IN OCTOBER 2020 BY FOUR FOUNDERS having complementary and internationally recognized expertise in the fields of neurosciences, research, finances and industrial development.